🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Cohort Study of Patients With Infective Endocarditis at Pitié-Salpêtrière Hospital

Recruitingn/aAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT04992923 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Infective endocarditis (IE) is a severe condition associated with high mortality. Due to the relative low prevalence of IE, prospective data are lacking and current guidelines are mostly based on expert consensus with low level of evidence. IE is also associated with severe complications especially strokes that occur in about one third of the patients. In order to improve the management and the prognosis of IE, clinical data from larges prospective cohort studies are needed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with confirmed IE according to European Society of Cardiology criteria Exclusion Criteria: * Opposition of the patient to participate
💊

What it tests

  • Not listed
📍

Where

1 site
APHP Pitié-Salpêtrière Hospital, Department of Cardiology
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy